Product Information
BUPRENORPHINE 8 MG TABLET SL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5616 per EA under NDC 00054017713. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
8 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054017713
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078633On Market Since
10/8/2009
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 8 MG TABLET SL has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5616 per EA |
|---|---|
| All-time high | $2.1825 (Mar 12, 2014) |
| All-time low | $0.5567 (Apr 22, 2026) |
| 52-week high | $0.7497 |
| 52-week low | $0.5567 |
| Median price | $0.9509 |
| Average price | $1.1978 |
| Largest weekly change | +27.5% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 8 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 8 MG TABLET SL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5616 per EA (NDC 00054017713), effective Jun 24, 2026.
How has the price of BUPRENORPHINE 8 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 8 MG TABLET SL has declined 73.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 8 MG TABLET SL?
Since Nov 28, 2013, the NADAC for BUPRENORPHINE 8 MG TABLET SL has ranged from a low of $0.5567 (Apr 22, 2026) to a high of $2.1825 (Mar 12, 2014), with a median of $0.9509 per EA.
Are there cheaper alternatives to BUPRENORPHINE 8 MG TABLET SL?
5 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE 8 MG TABLET SL, but none are currently priced below it.
Who manufactures BUPRENORPHINE 8 MG TABLET SL?
BUPRENORPHINE 8 MG TABLET SL (NDC 00054017713) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification